# Mifepristone Outpatient Labour Induction

> **NCT05177510** · PHASE2 · RECRUITING · sponsor: **Chelsea and Westminster NHS Foundation Trust** · enrollment: 400 (estimated)

## Conditions studied

- Labor, Induced

## Interventions

- **DRUG:** Mifepristone
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT05177510
- **Lead sponsor:** Chelsea and Westminster NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-25
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 400 (ESTIMATED)
- **Last updated:** 2025-09-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05177510

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05177510, "Mifepristone Outpatient Labour Induction". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT05177510. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*